The Right Coast |
|
|
Thoughts from San Diego on Law, Politics, and Culture
Right Coasters
Gail Heriot Saikrishna Prakash Michael Rappaport Maimon Schwarzschild Thomas Smith Christopher Wonnell Email Us Gail Heriot Saikrishna Prakash Michael Rappaport Maimon Schwarzschild Thomas Smith Christopher Wonnell Links Andrew Sullivan Atlantic Blog The Buck Stops Here Corporate Law Blog Crescat Sententia Crooked Timber Curmudgeonly Clerk Daniel Drezner En Banc EveTushnet.Com FreeSpace How Appealing Instapundit Law and Econ Blog Little Green Footballs Legal Theory Blog The Leiter Reports Marginal Revolution Overlawyered Pejmanesque ProfBainbridge.Com Punishment Theory Rasmusen Weblog SFA Politics & Relig Southern Appeal SpoonsExperience USS Clueless The Volokh Conspiracy The Yin Blog Archives The Bear Flag League Aaron's Rantblog (LA) Absinthe & Cookies Accidental Jedi (Fres) Angry Clam (LA) Baldilocks BlogoSFERICS (Expat) BoifromTroy (LA) CalBlog (Los Angeles) California Republic Citizen Smash(SD) Cobb (Los Angeles) Daily Pundit (SF) Dale Franks e-Claire(Northern CA) Fresh Potatoes(Orang) Infinite Monkeys The Interocitor (LA) The Irish Lass (Sacra) Left Coast Conserv. Lex Communis (Fres) Master of None (LA) Miller's Time (Sac) Molly's Musings (SD) Mulatto Boy (LA) Howard Owens (Vent) Pathetic Earthlings) Patio Pundit Patterico's Pontifications(LA) PrestoPundit (Orange) QandO Right on the Left Beach Shark Blog (Expat) Slings and Arrows (SD) So. Cal Law Blog (LA) Tone Cluster Window Manager Xrlq (Orange) 
|
October 19, 2004
The Flu Vaccine Shortage: Another Example of Regulatory Failure By Mike Rappaport Kevin Drum has a good post on this. (Hat tip: Instapundit) After reviewing several possible explanations for the shortage, he concludes: That leaves explanation #5 (the FDA regulations have gotten tighter over the years, and vaccine makers have had an increasingly hard time meeting them because it requires expensive plant upgrades). And at first glance it seems the most likely to be the real deal. The FDA has a famously tight regulatory regime, made even tighter in the late 90s, and as a result the United States has only two approved manufacturers of flu vaccine while Britain has half a dozen. The bottom line is that there are other flu vaccine manufacturers besides Chiron and Aventis, but they don't sell into the U.S. market because the cost of complying with FDA regulations is higher than the narrow profits they could expect to make from selling flu vaccine. |